Cervenakova Larisa, Yakovleva Oksana, McKenzie Carroll, Kolchinsky Svetlana, McShane Lisa, Drohan William N, Brown Paul
Jerome H Holland Laboratory for the Biomedical Sciences, Red Cross, Rockville, MD 20855, USA.
Transfusion. 2003 Dec;43(12):1687-94. doi: 10.1046/j.0041-1132.2003.00586.x.
The possible transmission of variant CJD (vCJD) through blood transfusion or use of plasma-derived products prompted this study comparing infectivity in murine models of vCJD and Gerstmann-Sträussler-Scheinker (GSS) disease, a non-vCJD form of transmissible spongiform encephalopathy (TSE).
RIII/Fa/Dk (RIII) or Swiss-Webster (Swiss) mice were inoculated intracerebrally (IC) with mouse-adapted strains of vCJD or GSS (Fukuoka-1) of similar infectivity. Groups of RIII mice were euthanized 17 weeks after inoculation (during the incubation period), and another 23 weeks after inoculation (when symptomatic). Blood was collected, separated into components, and inoculated into groups of healthy mice; brains and spleens from all mice were harvested and tested for the presence of PrPres by Western blot using 6H4 MoAb.
Levels of 20-30 infectious doses per mL were present in buffy coat and plasma during both the incubation and symptomatic stages of disease; PLT pellet infectivity was lower (10 ID/mL) and RBCs were not infectious. The disease was transmitted more efficiently by IV than IC inoculation of plasma, but there was no difference observed with inoculation of buffy coat. The incubation period was shorter after IC inoculation of GSS- than vCJD-brain inocula. The amount of PrPres in spleens was similar for both TSE agents, but was slightly lower in brains of vCJD than GSS mice.
Infectivity was detected in blood components of mice infected with a human-derived strain of vCJD during both the preclinical and clinical phases of disease in a similarly low range of concentrations as in mice infected with a human-derived nonvariant strain (GSS, Fukuoka-1). Other measures of virulence, including brain infectivity titers, incubation periods, and the accumulation of PrPres in spleens and brains, were also comparable in both experimental models.
变异型克雅氏病(vCJD)可能通过输血或使用血浆衍生产品传播,促使本研究比较vCJD和格斯特曼-施特劳斯勒-谢inker病(GSS)(一种非vCJD形式的传染性海绵状脑病(TSE))在小鼠模型中的传染性。
将RIII/Fa/Dk(RIII)或瑞士韦伯斯特(Swiss)小鼠脑内接种传染性相似的vCJD或GSS(福冈-1)小鼠适应株。接种后17周(潜伏期)和接种后23周(出现症状时)对RIII小鼠组实施安乐死。采集血液,分离成各成分,并接种到健康小鼠组;收集所有小鼠的脑和脾,使用6H4单克隆抗体通过蛋白质印迹法检测是否存在PrPres。
在疾病的潜伏期和症状期,血沉棕黄层和血浆中的感染剂量水平均为每毫升20 - 30个感染剂量;血小板沉淀的传染性较低(每毫升10个感染剂量),红细胞无传染性。静脉注射血浆比脑内接种血浆传播疾病更有效,但接种血沉棕黄层未观察到差异。接种GSS脑匀浆后比接种vCJD脑匀浆后的潜伏期更短。两种TSE病原体在脾脏中的PrPres量相似,但vCJD小鼠脑内的PrPres量略低于GSS小鼠。
在感染人源vCJD株的小鼠血液成分中,在疾病的临床前和临床阶段均检测到传染性,其浓度范围与感染人源非变异株(GSS,福冈-1)的小鼠相似且较低。在两个实验模型中,其他毒力指标,包括脑感染滴度、潜伏期以及PrPres在脾脏和脑内的积累,也具有可比性。